[Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain]
- PMID: 18470541
- DOI: 10.1007/s00482-008-0672-6
[Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain]
Abstract
Objective: To write a systematic review on the etiology and pathophysiology of the fibromyalgia syndrome (FMS) and of chronic widespread pain (CWP).
Methods: An interdisciplinary level-3 guideline (i.e. systematic literature search and assessment, logic analysis, formal consensus procedure) for the diagnosis and therapy of FMS was created in cooperation with 10 medical and psychological societies and 2 patient self-help organizations. A literature search was performed covering all available review articles on the etiology and pathophysiology of FMS and CWP using the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-2006), PsychInfo (1966-12/2006), and Scopus (1980-12/2006). For the assignment of evidence classes the system of the Oxford Centre for Evidence-Based Medicine was applied. Consensus was achieved by a multi-step nominal group procedure.
Results: FMS aggregates in families (evidence level 2c). Physical and psychological stress at the workplace are risk factors for the development of CWP and FMS. Affective disorders are risk factors for the development and maintenance of FMS. Operant learning mechanisms and sensitization are risk factors for the chronification of FMS (evidence levels 2b). Several factors are associated with the pathophysiology of FMS, but the causal relationship is unclear. This includes alterations of central pain pathways, hyporeactivity of the hypothalamus-pituitary-adrenal axis, increased systemic pro-inflammatory and reduced anti-inflammatory cytokine profiles and disturbances in the dopaminergic and serotonergic systems.
Conclusions: FMS is the common final product of various etiological factors and pathophysiological mechanisms.
Similar articles
-
[Pharmacological treatment of fibromyalgia syndrome].Schmerz. 2008 Jun;22(3):313-23. doi: 10.1007/s00482-008-0676-2. Schmerz. 2008. PMID: 18458958 German.
-
[Definition, classification and diagnosis of fibromyalgia syndrome].Schmerz. 2008 Jun;22(3):255-66. doi: 10.1007/s00482-008-0671-7. Schmerz. 2008. PMID: 18478271 German.
-
[Definition, classification and diagnosis of fibromyalgia syndrome].Z Rheumatol. 2008 Dec;67(8):665-6, 668-72, 674-6. doi: 10.1007/s00393-008-0404-4. Z Rheumatol. 2008. PMID: 19050952 German.
-
[Etiology and pathophysiology of fibromyalgia syndrome].Schmerz. 2012 Jun;26(3):259-67. doi: 10.1007/s00482-012-1174-0. Schmerz. 2012. PMID: 22760458 German.
-
[Multicomponent therapy for treatment of fibromyalgia syndrome].Schmerz. 2008 Jun;22(3):334-8. doi: 10.1007/s00482-008-0678-0. Schmerz. 2008. PMID: 18463898 German.
Cited by
-
The hypothalamus: specific or nonspecific role in the pathophysiology of trigeminal autonomic cephalalgias?Curr Pain Headache Rep. 2011 Apr;15(2):101-7. doi: 10.1007/s11916-010-0166-y. Curr Pain Headache Rep. 2011. PMID: 21128020 Review.
-
[Visualization of a myth--the new S3 guidelines for fibromyalgia syndrome].Schmerz. 2009 Feb;23(1):72-4; author reply 74-6. doi: 10.1007/s00482-008-0765-2. Schmerz. 2009. PMID: 19156447 German. No abstract available.
-
Circulating Omentin-1 and Chronic Painful Temporomandibular Disorders.J Oral Facial Pain Headache. 2016 Summer;30(3):203-9. doi: 10.11607/ofph.1608. J Oral Facial Pain Headache. 2016. PMID: 27472522 Free PMC article.
-
Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.Pain Ther. 2015 Dec;4(2):169-78. doi: 10.1007/s40122-015-0038-6. Epub 2015 Sep 3. Pain Ther. 2015. PMID: 26334329 Free PMC article.
-
Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review.Rheumatol Int. 2012 Sep;32(9):2593-9. doi: 10.1007/s00296-011-2348-2. Epub 2011 Dec 31. Rheumatol Int. 2012. PMID: 22210272 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous